ArticleMacromolecular bioscience2026
Mesenchymal Stem Cell-Laden Nanofibril-Reinforced Injectable and Self-Healing Alginate Dialdehyde/Gelatin Hydrogels with Enhanced Mechanical and Chondrogenic Performance In Vitro.
Article in Macromolecular bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Injectable hydrogels offer a minimally invasive approach for cartilage repair, enabling precise defect filling and in situ scaffold formation; however, balancing mechanical strength with stem cell viability and chondrogenic differentiation remains challenging. Here, alginate dialdehyde-gelatin (ADAG) hydrogels are reinforced with cellulose nanofibrils (CNFs) to enhance mechanical performance while retaining injectability, rapid self-healing, and chondroinductive properties. FTIR spectroscopy confirms efficient Schiff base cross-linking between ADA and gelatin, with CNF incorporation preserving chemical integrity. SEM imaging revealed a porous, interconnected architecture, with the 9:1 (ADAG: CNF, v/v) hydrogel exhibiting a more homogeneous and compact network structure, similar to ADAG. Optimization identifies 9:1 and 8:2 ratios as maintaining crosslinking density, while 7:3 ratio slightly disrupts uniformity but retains fast gelation (<5 min) and smooth injectability. CNF reinforcement markedly enhanced mechanical properties, as evidenced by increased storage modulus (0.007 MPa) and compressive modulus (0.006 MPa). The hydrogels exhibit high self-healing efficiency (98%) and support robust proliferation of human bone marrow-derived mesenchymal stem cells. Biochemical and gene-expression analyses show enhanced glycosaminoglycan and collagen deposition, upregulation of chondrogenic markers (SOX9, COL2A1, ACAN), and low COL1A1 expression. Overall, CNF-reinforced ADAG hydrogels combine cytocompatibility, mechanical resilience, injectability, and chondroinductive potential, highlighting suitability for stem cell-mediated cartilage tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.